Cognitive Status After Removal of Skull Base Meningioma
Part of paid clinical trials in Columbus, Ohio.
- Sponsor
- Ohio State University
- Study ID
- NCT04635657
- Status
- Recruiting
Conditions
- Cognitive Decline
- Cognitive Impairment
- Frontal Meningioma
- Meningioma
- Post-Surgical Cognition
- Skull Base Meningioma
- Temporal Meningioma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 89 Years
- Healthy Volunteers
- Not accepted
Interventions
- Long-term Cognitive testing — OTHERThese patients will undergo their standard of care cognitive testing at baseline, six weeks post-operatively and one year post-operatively.
Study Details
The purpose of this prospectively enrolling trial is to assess long-term cognitive outcomes of patients undergoing surgery for resection of a meningioma associated with the frontal and temporal lobes.
Key Dates
- Start date
- Dec 10, 2019
- Status verified
- May 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 50 participants (estimated)
Arms
- Arm: Meningioma GroupThis group will include all patients in the study, regardless of location (frontal or temporal lobe) or surgical approach (endoscopic endonasal or craniotomy). Fifty patients will be included in the cohort
Primary Outcome Measure
Overall cognitive function [ Time Frame: 12 months ]
Central Contacts
- Emma Kurtz, BS(614) 685-4534
- Uchechi Okafor, BS614-293-4876
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | Daniel Prevdello, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Columbus, OH
By research site
Related Studies
- Lutathera for Treatment of Recurrent or Progressive High-Grade CNS TumorsPHASE1/PHASE2 · Recruiting · Nationwide Children's Hospital · Aurora, Colorado
- REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage StudyEnrolling By Invitation · Johns Hopkins University · Birmingham, Alabama
- Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive TumorsPHASE1/PHASE2 · Recruiting · Perspective Therapeutics · Jacksonville, Florida
- Essential Fats For Enhancing Cognitive Thinking (EFFECT) StudyRecruiting · Ohio State University · Columbus, Ohio